COMP <GO>
MXL vs SLAB // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
MaxLinear Inc. (NASDAQ) VS. Silicon Laboratories Inc. (NASDAQ) • 15-METRIC TALLY: MXL 1
— SLAB 10
■ METRIC PARITY
LAST: $61.33 (-9.10%) • MKT CAP: $6.14B
options-implied-move
—
LAST: $222.10 (-0.16%) • MKT CAP: $7.42B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MXL VS. SLAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MXL | SLAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.80% | 58.20% | -1.40 | SLAB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -19.20% | -6.90% | -12.30 | SLAB | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.11% | 0.89% | -0.78 | SLAB | /fcf-yield <GO> |
| Operating Margin | -27.10% | -9.00% | -18.10 | SLAB | /operating-margins <GO> |
| Net Profit Margin | -29.20% | -8.30% | -20.90 | SLAB | /net-margins <GO> |
| Revenue Growth (YoY) | 29.70% | 34.30% | -4.60 | SLAB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.63 | 26.00 | -15.37 | SLAB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.8 | 62.9 | -21.10 | SLAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 1.42 | -0.29 | SLAB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 31.0x | -9.00 | MXL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.14B | $7.42B | -$1.28B | SLAB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MXL REV | SLAB REV | MXL GROSS % | SLAB GROSS % | MXL FCF | SLAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $467.6M | $784.8M | 56.8% | 58.2% | $7.0M | $65.8M |
| FY 2024 | $360.5M | $584.4M | 54.0% | 53.4% | -$63.0M | -$25.7M |
| FY 2023 | $693.3M | $782.3M | — | — | $12.2M | -$65.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MXL // BETA 1.13
SLAB // BETA 1.42